Why Green Thumb Industries Stock Trounced Market on Tuesday

Summarize this article with:
By Eric Volkman – Dec 16, 2025 at 4:19PM ESTKey PointsPresident Trump made some very encouraging remarks about marijuana law reform.However, he stopped short of promising he'd sign an executive order jump-starting the process of the drug's reclassification.These 10 Stocks Could Mint the Next Wave of Millionaires ›For hardly the first time in recent days, investors have become excited about the prospect of a significant change in U.S. drug laws.Will he or won't he? This is the question that's been front of mind for many marijuana stock investors over the past few days, as both credible media reports and President Trump himself fueled speculation that he will begin the process of decriminalizing the drug. Comments from the President late Monday injected new bullishness into weed stocks the following day. Sector mainstay Green Thumb Industries (GTBIF +14.71%) surged more than 14% higher on this development. Weed-supporting words In a press conference in the White House's Oval Office, the President was asked whether he would issue an executive order (EO) directing the Justice Department to start the process of rescheduling pot. Image source: Getty Images. "We are considering that, yeah," Trump responded, "because a lot of people want to see it, the reclassification, because it leads to tremendous amounts of research that can't be done unless you reclassify. So we're looking at that very strongly." Although he stopped short of a hard promise to issue that EO, his remarks were taken as one of the clearest indications yet that he would do so in the very near future.Advertisement ExpandOTC: GTBIFGreen Thumb IndustriesToday's Change(14.71%) $1.24Current Price$9.63Key Data PointsMarket Cap$1.9BDay's Range$8.48 - $9.9552wk Range$4.63 - $10.10Volume1.6MAvg Vol489KGross Margin48.93% A massive change is (probably) coming If rescheduling were to occur, it would de facto legalize marijuana throughout the U.S. This would be a monumental and historically significant event for the drug, not to mention the struggling industry that specializes in it. Although companies like Green Thumb will face challenges regardless of the legal environment, they'll have a much easier time conducting their business if the present restrictions are lifted. About the AuthorEric Volkman is a contributing Motley Fool finance and stock market analyst. Previously, Eric was an equities analyst at European investment bank Raiffeisen Capital and Investment. He’s also been a freelance finance writer since 1995. He studied at Susquehanna University.TMFVolkmanRead NextDec 15, 2025 •By Eric VolkmanWhy Tilray Stock Plunged TodayDec 12, 2025 •By Rich SmithWhy Canopy Growth Stock Popped TodayDec 12, 2025 •By Rich SmithWhy Aurora Cannabis Stock Just Rocketed HigherDec 12, 2025 •By Rich SmithWhy Tilray Stock Lit Up TodayDec 6, 2025 •By Prosper Junior BakinyThis Stock-Split Stock Is Up 90% in the Past 6 Months: Is There More Upside Ahead?Dec 5, 2025 •By Eric VolkmanWhy Tilray Stock Dived by 10% This Week
